Naomi Kresge Bloomberg
- All
- News
-
Obesity Drugs Won't Solve Our Billion-Person Problem, WHO Warns
Effective, popular obesity medications won't be enough to solve a worldwide problem that now affects more than 1 billion people, World Health Organization officials warned.
-
Super Contagious BA.5 Variant Fuels Fresh Surge In Infection In Europe
It was supposed to be a post-Covid-19 summer in Europe. Masks are gone in most places, and vacation season is in full swing as workers rush for the beaches and cities they missed in the two years marked by the pandemic.
-
Omicron Hospitalisation Risk Far Below Delta's In Early Studies
The Omicron variant of Covid-19 may be less likely to land patients in the hospital than the Delta strain, according to a trio of studies of preliminary data.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
On Omicron vs Vaccines, New Grounds For Cautious Optimism
The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters
-
Omicron Scare: Pfizer Says Third Dose Key To Fight Spread
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
Shots Should Protect From Worst Of Omicron, Says Big Vaccine-Maker
The current generation of Covid-19 vaccines probably will still protect against severe disease in people infected by the omicron variant, BioNTech SE Chief Executive Officer Ugur Sahin said.
-
BioNTech Is Working On An 'Omicron' Version Of Its Covid Shot
BioNTech SE is working to adapt its Covid-19 vaccine to address the 'Omicron' variant and expects to have a new version ready within 100 days if necessary.
-
Travel Bans, Snap Defences Buy Time As Scientists Race To Decode Omicron
Travel bans and other snap defenses that countries threw up against omicron, the new Covid-19 variant, are buying time for scientists to answer key questions that could prevent another wave of deaths.
-
Delta Gives Vaccinated People Same Virus Amount As Unvaccinated: Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
Vaccines Less Effective Against Delta, Booster Shot Helps: UK Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
UK's Big New Study On Severe Covid Cases
One in two people hospitalized with COVID-19 develop another health complication, a UK study showed, in the broadest look yet at what happens to those sick enough to need inpatient treatment.
-
Pfizer Vaccine Data In Israel Gives Clues On Herd Immunity: Scientists
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
-
Norway Warns of Vaccination Risks For Sick Elderly Patients After 23 Die
Norway said Covid-19 vaccines may be too risky for the very old and terminally ill, the most cautious statement yet from a European health authority as countries assess the real-world side effects of the first shots to gain approval.
-
Obesity Drugs Won't Solve Our Billion-Person Problem, WHO Warns
Effective, popular obesity medications won't be enough to solve a worldwide problem that now affects more than 1 billion people, World Health Organization officials warned.
-
Super Contagious BA.5 Variant Fuels Fresh Surge In Infection In Europe
It was supposed to be a post-Covid-19 summer in Europe. Masks are gone in most places, and vacation season is in full swing as workers rush for the beaches and cities they missed in the two years marked by the pandemic.
-
Omicron Hospitalisation Risk Far Below Delta's In Early Studies
The Omicron variant of Covid-19 may be less likely to land patients in the hospital than the Delta strain, according to a trio of studies of preliminary data.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
On Omicron vs Vaccines, New Grounds For Cautious Optimism
The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters
-
Omicron Scare: Pfizer Says Third Dose Key To Fight Spread
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
Shots Should Protect From Worst Of Omicron, Says Big Vaccine-Maker
The current generation of Covid-19 vaccines probably will still protect against severe disease in people infected by the omicron variant, BioNTech SE Chief Executive Officer Ugur Sahin said.
-
BioNTech Is Working On An 'Omicron' Version Of Its Covid Shot
BioNTech SE is working to adapt its Covid-19 vaccine to address the 'Omicron' variant and expects to have a new version ready within 100 days if necessary.
-
Travel Bans, Snap Defences Buy Time As Scientists Race To Decode Omicron
Travel bans and other snap defenses that countries threw up against omicron, the new Covid-19 variant, are buying time for scientists to answer key questions that could prevent another wave of deaths.
-
Delta Gives Vaccinated People Same Virus Amount As Unvaccinated: Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
Vaccines Less Effective Against Delta, Booster Shot Helps: UK Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
UK's Big New Study On Severe Covid Cases
One in two people hospitalized with COVID-19 develop another health complication, a UK study showed, in the broadest look yet at what happens to those sick enough to need inpatient treatment.
-
Pfizer Vaccine Data In Israel Gives Clues On Herd Immunity: Scientists
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.
-
Norway Warns of Vaccination Risks For Sick Elderly Patients After 23 Die
Norway said Covid-19 vaccines may be too risky for the very old and terminally ill, the most cautious statement yet from a European health authority as countries assess the real-world side effects of the first shots to gain approval.
